Clincosm LogoSign in Get a demo

Non Small Cell Lung Cancer

Showing NaN - NaN of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer Trial in Worldwide (Pemetrexed, Cisplatin, Necitumumab)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • Nyack, New York
  • +100 more
Dec 12, 2021

Non Small Cell Lung Cancer Trial in Spain (Nivolumab 360 mg, Paclitaxel 200mg/m2, Carboplatin AUC 6)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Nivolumab 360 mg
  • +2 more
  • La Coruña, Coruña, Spain
  • +23 more
Sep 21, 2021

Non Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma, Triple Negative Breast Cancer Trial in Worldwide (CAN04,

Recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • CAN04
  • +3 more
  • Salzburg, Austria
  • +27 more
Aug 4, 2021

Non Small Cell Lung Cancer Trial in Worldwide (Pharmacokinetic sampling - AZD9291, Rifampicin, AZD9291 tablet dosing)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • Pharmacokinetic sampling - AZD9291
  • +4 more
  • Atlanta, Georgia
  • +17 more
Jun 18, 2021

Non Small Cell Lung Cancer Trial in Worldwide (OSE2101, Docetaxel, Pemetrexed)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Burbank, California
  • +76 more
Mar 5, 2021

Non Small Cell Lung Cancer Trial in Worldwide (HM61713)

Terminated
  • Non Small Cell Lung Cancer
  • Beverly Hills, California
  • +71 more
Jan 17, 2021

Non Small Cell Lung Cancer Trial in Australia, New Zealand, Spain (Demcizumab)

Completed
  • Non Small Cell Lung Cancer
  • Herston, Queensland, Australia
  • +6 more
Sep 7, 2020

Non Small Cell Lung Cancer Trial in France, Spain, United States (AC0010MA)

Terminated
  • Non Small Cell Lung Cancer
  • Duarte, California
  • +7 more
Oct 28, 2019

Nivolumab in Real World: Analysis of Expanded Use in Spanish

Completed
  • Non Small Cell Lung Cancer
  • Nivolumab 10 MG/ML
  • Alcoy, Alicante, Spain
  • +60 more
Nov 12, 2018

Non Small Cell Lung Cancer Trial in Worldwide (Pharmacokinetic sampling - AZD9291, AZD9291 tablet dosing, Rosuvastatin)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • Pharmacokinetic sampling - AZD9291
  • +4 more
  • Fairfax, Virginia
  • +12 more
Jul 2, 2018

Non Small Cell Lung Cancer Trial in Worldwide (AZD6244, docetaxel, Placebo)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • Los Angeles, California
  • +63 more
May 22, 2018

Non Small Cell Lung Cancer Trial in Germany, Spain (Pemetrexed, Cisplatin, LY2603618)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • Mannheim, Baden-Wurttemberg, Germany
  • +23 more
May 16, 2018

Non Small Cell Lung Cancer Trial in Worldwide (Vandetanib, Erlotinib)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • Berkeley, California
  • +152 more
Jan 24, 2018

Locally Advanced Solid Tumor, Metastatic Solid Tumor, Breast Cancer Trial in Italy, Spain, United States (MSC1936369B

Completed
Has Results
  • Locally Advanced Solid Tumor
  • +5 more
  • MSC1936369B (pimasertib)
  • SAR245409 (PI3K and mTOR inhibitor)
  • Scottsdale, Arizona
  • +7 more
Jan 17, 2017

Non Small Cell Lung Cancer Trial in Worldwide (Pemetrexed, Cisplatin, Etoposide)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • Birmingham, Alabama
  • +132 more
May 20, 2016

Non Small Cell Lung Cancer Trial in Worldwide (AMG 386, AMG 386 Placebo, Pemetrexed)

Completed
  • Non Small Cell Lung Cancer
  • AMG 386
  • +3 more
  • Fayetteville, Arkansas
  • +34 more
May 18, 2016

Non Small Cell Lung Cancer Trial in Worldwide (BMS-690514, Erlotinib)

Completed
  • Non Small Cell Lung Cancer
  • New Haven, Connecticut
  • +29 more
Sep 23, 2015

T790M Mutation Positive 2nd Line STandard of cAre Registry

Withdrawn
  • Non Small Cell Lung Cancer
    • Kentucky, Kentucky
    • +49 more
    Jul 6, 2015

    Non Small Cell Lung Cancer Trial in Worldwide (Pemetrexed, Cisplatin, Thoracic Radiotherapy)

    Completed
    Has Results
    • Non Small Cell Lung Cancer
    • Le Mans, France
    • +20 more
    Mar 5, 2014

    Non Small Cell Lung Cancer Trial in Worldwide (Talactoferrin, Placebo)

    Completed
    • Non Small Cell Lung Cancer
    • Casa Grande, Arizona
    • +188 more
    Aug 13, 2012

    Epidermal Growth Factor Receptor Mutation Status in Newly

    Completed
    • Non Small Cell Lung Cancer
      • Santiago de Compostela, A Coruna, Spain
      • +23 more
      Mar 15, 2011